Genomic Validation of Endometrial Cancer Patient-Derived Xenograft Models as a Preclinical Tool

Genomic Validation of Endometrial Cancer Patient-Derived Xenograft Models as a Preclinical Tool

Endometrial cancer (EC) is the second most frequent gynecological cancer worldwide. Although improvements in EC classification have enabled an accurate establishment of disease prognosis, women with a high-risk or recurrent EC face a dramatic situation due to limited further treatment options. There...

Full description

Bibliographic Details
Main Authors: Beatriz Villafranca-Magdalena, Carina Masferrer-Ferragutcasas, Carlos Lopez-Gil, Eva Coll-de la Rubia, Marta Rebull, Genis Parra, Ángel García, Armando Reques, Silvia Cabrera, Eva Colas, Antonio Gil-Moreno, Cristian P. Moiola
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:International Journal of Molecular Sciences
Subjects:
endometrial cancer
preclinical model
PDXs
personalized medicine
translational research
genomics
Online Access:https://www.mdpi.com/1422-0067/23/11/6266

Internet

https://www.mdpi.com/1422-0067/23/11/6266

Similar Items